References
1. Thébaud B, Goss KN, Laughon M, Whitsett JA, Abman SH, Steinhorn RH, et al. Bronchopulmonary dysplasia. Nat Rev Dis Primers. 2019;5(1):78.2. Bamat NA, Nelin TD, Eichenwald EC, Kirpalani H, Laughon MM, Jackson WM, et al. Loop Diuretics in Severe Bronchopulmonary Dysplasia: Cumulative Use and Associations with Mortality and Age at Discharge. J Pediatr. 2021;231:43-9.e3.3. Nelin TD, Lorch S, Jensen EA, Alexiou S, Gibbs K, Napolitano N, et al. The association between diuretic class exposures and enteral electrolyte use in infants developing grade 2 or 3 bronchopulmonary dysplasia in United States children’s hospitals. Journal of perinatology : official journal of the California Perinatal Association. 2021;41(4):779-85.4. Kao LC, Warburton D, Sargent CW, Platzker AC, Keens TG. Furosemide acutely decreases airways resistance in chronic bronchopulmonary dysplasia. J Pediatr. 1983;103(4):624-9.5. Greenberg RG, Gayam S, Savage D, Tong A, Gorham D, Sholomon A, et al. Furosemide Exposure and Prevention of Bronchopulmonary Dysplasia in Premature Infants. J Pediatr. 2019;208:134-40.e2.6. Prandota J. Furosemide: progress in understanding its diuretic, anti-inflammatory, and bronchodilating mechanism of action, and use in the treatment of respiratory tract diseases. Am J Ther. 2002;9(4):317-28.7. Patel H, Yeh TF, Jain R, Pildes R. Pulmonary and renal responses to furosemide in infants with stage III-IV bronchopulmonary dysplasia. American journal of diseases of children (1960). 1985;139(9):917-9.8. Guignard JP, Iacobelli S. Use of diuretics in the neonatal period. Pediatr Nephrol. 2021;36(9):2687-95.9. E ÓB, Byrne AO, Dowling J, Kiernan J, Lynch JCR, Alomairi L, et al. Diuretics use in the management of bronchopulmonary dysplasia in preterm infants: A systematic review. Acta Paediatr. 2024;113(3):394-402.10. Guaman MC, Gien J, Baker CD, Zhang H, Austin ED, Collaco JM. Point Prevalence, Clinical Characteristics, and Treatment Variation for Infants with Severe Bronchopulmonary Dysplasia. Am J Perinatol. 2015;32(10):960-7.11. Armoni Domany K, Amirav I, Sadot E, Diamant N, Mandel D, Lavie M. Weaning Strategy of Diuretics in Outpatient Preterm Infants with Bronchopulmonary Dysplasia: A National Survey. Am J Perinatol. 2022;39(4):394-400.12. Dawson SK, D’Andrea LA, Lagatta JM. Management of diuretics in infants with bronchopulmonary dysplasia discharged on home oxygen. Pediatr Pulmonol. 2023;58(2):522-9.13. Cristea AI, Ren CL, Amin R, Eldredge LC, Levin JC, Majmudar PP, et al. Outpatient Respiratory Management of Infants, Children, and Adolescents with Post-Prematurity Respiratory Disease: An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2021;204(12):e115-e33.14. Duijts L, van Meel ER, Moschino L, Baraldi E, Barnhoorn M, Bramer WM, et al. European Respiratory Society guideline on long-term management of children with bronchopulmonary dysplasia. Eur Respir J. 2020;55(1).15. Kapur N, Nixon G, Robinson P, Massie J, Prentice B, Wilson A, et al. Respiratory management of infants with chronic neonatal lung disease beyond the NICU: A position statement from the Thoracic Society of Australia and New Zealand. Respirology. 2020;25(8):880-8.16. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163(7):1723-9.17. Oken E, Kleinman KP, Rich-Edwards J, Gillman MW. A nearly continuous measure of birth weight for gestational age using a United States national reference. BMC Pediatr. 2003;3:6.18. Ryan RM, Keller RL, Poindexter BB, D’Angio CT, Shaw PA, Bellamy SL, et al. Respiratory Medications in Infants <29 Weeks during the First Year Postdischarge: The Prematurity and Respiratory Outcomes Program (PROP) Consortium. J Pediatr. 2019;208:148-55.e3.19. White H, Berenson A, Mannan J, Feldman HA, Rhein L. Utilization trends of respiratory medication in premature infants discharged on home oxygen therapy. Pediatr Pulmonol. 2020;55(6):1359-65.20. Bhandari A, Alexiou S. Outpatient management of established bronchopulmonary dysplasia: An update. Semin Perinatol. 2023;47(6):151820.21. Collaco JM, Tracy MC, Sheils CA, Rice JL, Rhein LM, Nelin LD, et al. Insurance coverage and respiratory morbidities in bronchopulmonary dysplasia. Pediatr Pulmonol. 2022;57(7):1735-43.22. McGlynn JR, Aoyama BC, Martin A, Collaco JM, McGrath-Morrow SA. Outpatient respiratory outcomes in children with BPD on supplemental oxygen. Pediatr Pulmonol. 2023;58(5):1535-41.